SCHEMBL24263245

SCHEMBL24263245

Cn1nc2c(cc1=O)CC(NC(=O)C1CCCCC1)CC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
HTR2C P28335 1/20 0.41
LMNA P02545 4/20 0.41
POLB P06746 1/20 0.41
TSHR P16473 3/20 0.40
TP53 P04637 2/20 0.39
MAPT P10636 1/20 0.38
EPHX2 P34913 1/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 1/20 0.38
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
GAA P10253 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24263086 0.94 HTR2C (0.44) ALDH1A1HTR2CLMNAPOLBTSHR
SCHEMBL24263232 0.84 MTNR1A (0.49) ALDH1A1CA12CA1CA2CA7
SCHEMBL24263217 0.81 HTR2C (0.43) ALDH1A1CA1CA2HTR2CLMNA
SCHEMBL24263220 0.79 MTNR1A (0.54) CA12CA1CA2CA7CA9
SCHEMBL24263210 0.78 MTNR1A (0.47) ALDH1A1HTR2CHPGDMTNR1AMTNR1B
SCHEMBL24263083 0.77 NPC1 (0.46) ALDH1A1HTR2CLMNAPOLBTSHR
SCHEMBL24263099 0.76 HDAC8 (0.41) ALDH1A1HTR2CLMNATP53HPGD
SCHEMBL24263133 0.76 NPC1 (0.45) ALDH1A1HTR2CPOLBTSHRHPGD
SCHEMBL24263096 0.76 ALDH1A1 (0.40) ALDH1A1HTR2CTSHRTP53HPGD
SCHEMBL24263243 0.76 GAA (0.43) ALDH1A1CA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022040508-A1 COMPOUNDS AND METHODS FOR TREATING AUTOIMMUNE DISORDERS BY TARGETING HLA-DQ2 IMMUNOMOLECULAR THERAPEUTICS, INC. (US) 2022-02-24 WO disclosed